A comprehensive system of corporate governance is in place which encompasses every sphere of management, from action plans and internal controls to performance measurement and corporate disclosure to the best interest of everyone ranging from the board of directors, management, shareholders to customers, employees and society.
Regular meetings of Ethical and Corporate Governance Committee are held on monthly basis under the aegis of Mr. Lov Verma along with invited guests from different fields.
These meetings have provided Pharmazz the guidelines as to how the company can be directed or controlled such that it can fulfil its goals and objectives in a manner that adds to the value of the company and is also beneficial for all stakeholders in the long term.
PMZ-2123 prevents the development of neurological complications in diabetic ketoacidosis patients.
Intravenous administration of PMZ-2123 prevents the development of cerebral edema in patients of diabetic ketoacidosis. Efficacy has been demonstrated in animal models of diabetic ketoacidosis.
Patents issued in United States, Japan, European Union, Australia, China and Canada.
PMZ-2123 has been safely used in humans as an investigational agent (NCT00115583; NCT00915070; NCT01658410).